Zhiyong Xu

Breast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route

Abstract Background Breast metastasis from extramammary malignancies is rare, with ovarian cancer being an exceptionally uncommon primary source. These metastases frequently mimic primary breast carcinoma, posing substantial diagnostic and therapeutic challenges. Case presentatio...